Close
Almac
Achema middle east

Press Releases

Sangamo And Bioverativ Announce FDA Acceptance Of IND Application For ST-400

Sangamo Therapeutics, Inc. the leader in therapeutic genome editing, and Bioverativ Inc. (NASDAQ: BIVV), a global biopharmaceutical company focused on the discovery, development, and commercialization of innovative therapies for hemophilia and other rare blood disorders, announced today that the...

TrialScope Tackles Issue of “Sharing Clinical Trial Results with Patients” at CBI Conference; Presents Sponsor Survey Findings

TrialScope, the global leader in clinical trial transparency and compliance solutions, announced new findings from its sponsor survey on clinical trial results sharing practices, at CBI’s second annual Plain Language Summit in Philadelphia. The survey asked...

GSK receives approval for Benlysta in Japan for the treatment of systemic lupus erythematosus

GSK announced today that the Japanese Ministry of Health, Labour and Welfare (MHLW) has approved Benlysta (belimumab) for the treatment of adult patients with systemic lupus erythematosus (SLE) who are inadequate responders to existing therapies. Benlysta is for use...

Common Health Disorders in Children with Down Syndrome

Down syndrome is a genetic disorder that results in mental and physical developmental delays. In addition to these disabilities, individuals diagnosed with Down syndrome often develop certain health complications. It’s important to note that health complications...

Lonza Introduces the New CytoSMART™ 2 System for Live Cell Imaging

Lonza has introduced the CytoSMART™ 2 System, an updated version of Lonza’s popular CytoSMART™ System for live cell imaging. The CytoSMART™ 2 Device features an advanced optical system and more powerful camera unit, which enables researchers to capture higher-resolution...

Boris Johnson stresses ‘importance of the life sciences sector to the UK economy’ at TraceLink’s new European HQ launch

Foreign Secretary Boris Johnson has officially opened TraceLink’s new European headquarters in Uxbridge, UK. As the European pharmaceutical industry prepares for new serialization requirements set out in the Falsified Medicines Directive (FMD), the new headquarters will...

New In-situ Hydrolysis SPE Plates from Biotage

Biotage , a leading global supplier of solutions and technology for analytical, medicinal and peptide chemistry, is pleased to announce the launch of EVOLUTE® HYDRO, solid phase extraction plates with an integral Hydrolysis capability that enable chemists to perform...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate »